News|Articles|November 15, 2018

Pharmaceutical Technology

  • Pharmaceutical Technology-11-15-2018
  • Volume 2018 eBook
  • Issue 2

Precompetitive Research Spurs Innovation in Pharmaceutical Analysis

Industry–academia collaborations seek to address unmet needs in measurement science.

Precompetitive research is increasingly being considered as a cost-effective way to find solutions to widespread problems in the bio/pharmaceutical industry. Pharmaceutical Technology spoke with Christopher Welch, PhD, director of the Indiana Consortium for Analytical Sciences and Engineering (a joint venture between Purdue University, the University of Notre Dame, and Indiana University), about trends in pharmaceutical analysis and the consortium’s proposed Center for Bioanalytic Metrology, sponsored by the National Science Foundation. 

Read this article from Pharmaceutical Technology’s Best Practices for Today's Bio/Pharma Laboratory 2018 eBook.

Article Details

Pharmaceutical Technology
eBook: Best Practices for Today's Bio/Pharma Laboratory 2018
Vol. 42
November 2018
Pages: 10–13

Citation

When referring to this article, please cite it as J. Markarian, "Precompetitive Research Spurs Innovation in Pharmaceutical Analysis," Best Practices for Today's Bio/Pharma Laboratory 2018 eBook (November 2018).http://read.findpharma.com/i/1052795-pharmaceutical-technology-ebook/10


Related to this article

Are Your Supplier Selection and Oversight Processes Robust Enough?
Despite best efforts to ensure a contract organization is following GMPs, a warning letter is issued by the FDA. Susan J. Schniepp, distinguished fellow at Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, provide advice for create a robust supplier selection and oversight system.
white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.
Transitioning mRNA from R&D to GMP
Marco Pupo, PhD, innovation and development coordinator at Anemocyte, discusses the R&D-to-GMP transition and the changing shape of mRNA manufacturing facilities.